FDA Warning Letters to Foreign Facilities Soar in 2017
FDA warning letters to foreign drug and API manufacturing facilities have increased more than tenfold so far this year compared to the same period in 2016.
Source: Drug Industry Daily
FDA warning letters to foreign drug and API manufacturing facilities have increased more than tenfold so far this year compared to the same period in 2016.
Source: Drug Industry Daily